Your browser doesn't support javascript.
loading
Impact of vitamin D supplementation on adiposity in African-Americans.
Chandler, P D; Scott, J B; Drake, B F; Ng, K; Chan, A T; Hollis, B W; Emmons, K M; Giovannucci, E L; Fuchs, C S; Bennett, G G.
Affiliation
  • Chandler PD; 1] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA.
  • Scott JB; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA.
  • Drake BF; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
  • Ng K; 1] Harvard Medical School, Boston, MA, USA [2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chan AT; 1] Harvard Medical School, Boston, MA, USA [2] Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Hollis BW; Division of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
  • Emmons KM; 1] Harvard Medical School, Boston, MA, USA [2] Center for Community-Based Research, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Giovannucci EL; 1] Harvard Medical School, Boston, MA, USA [2] Department of Nutrition, Harvard School of Public Health, Boston, MA, USA [3] Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Fuchs CS; 1] Harvard Medical School, Boston, MA, USA [2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bennett GG; Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.
Nutr Diabetes ; 5: e147, 2015 Jan 19.
Article in En | MEDLINE | ID: mdl-25599559
BACKGROUND: African-Americans have higher rates of obesity-associated chronic diseases. Serum 25-hydroxyvitamin D (25(OH)D) shows an inverse association with obesity status. We investigated whether vitamin D supplementation changes body mass index (BMI). SUBJECTS: In total, 328 overweight African-Americans were enrolled over three consecutive winter periods (2007-2010) into a randomized, double-blind, placebo-controlled trial to receive cholecalciferol supplementation (0, 1000 international units (IU), 2000 IU or 4000 IU per day) for 3 months. Plasma concentrations of 25(OH)D and anthropometric measurements were done at baseline, 3 and 6 months. RESULTS: At 3 months, vitamin D supplementation in three dose groups (1000 IU, 2000 IU or 4000 IU per day) did not cause any significant changes in BMI as compared with placebo group 3-month change in BMI per 1000 IU per day estimate (SE): 0.01 (0.039); P=0.78. CONCLUSIONS: In overweight African-Americans, short-term high-dose vitamin D supplementation did not alter BMI.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nutr Diabetes Year: 2015 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Nutr Diabetes Year: 2015 Document type: Article Affiliation country: United States Country of publication: United kingdom